Baillie Gifford & Co Portfolio holdings
Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.
Top Buys
| 1 |
WUBA
58.COM INC
WUBA
|
$220M |
| 2 |
Stellantis
STLA
|
$215M |
| 3 |
Shopify
SHOP
|
$109M |
| 4 |
Itaú Unibanco
ITUB
|
$67.5M |
| 5 |
ICICI Bank
IBN
|
$61.8M |
Top Sells
| 1 |
NBIS
Nebius Group N.V. Class A Ordinary Shares
NBIS
|
$463M |
| 2 |
Amazon
AMZN
|
$325M |
| 3 |
MBLY
Mobileye N.V.
MBLY
|
$319M |
| 4 |
Alibaba
BABA
|
$295M |
| 5 |
AMTD
TD Ameritrade Holding Corp
AMTD
|
$253M |
Sector Composition
| 1 | Consumer Discretionary | 37.3% |
| 2 | Communication Services | 18.48% |
| 3 | Healthcare | 13.51% |
| 4 | Technology | 8.97% |
| 5 | Financials | 8.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Pacira BioSciences
PCRX
$1.2B
| $12M | 0.02% |
320,582
+19,582
| +7% | +$735K |
|
|
STMP
152
DELISTED
Stamps.com, Inc.
STMP
| $11.8M | 0.01% |
58,048
-7,202
| -11% | -$1.46M |
|
|
VAR
153
DELISTED
Varian Medical Systems, Inc.
VAR
| $11.7M | 0.01% |
117,375
+16,708
| +17% | +$1.67M |
|
154
British American Tobacco
BTI
$121B
| $11.7M | 0.01% |
+187,548
| New | +$11.7M |
|
|
ADAP
155
Adaptimmune Therapeutics
ADAP
$13.5M
| $11.3M | 0.01% |
1,379,304
+55,996
| +4% | +$459K |
|
|
BCRH
156
DELISTED
BLUE CAPITAL REINSURANCE HOLDINGS LTD.
BCRH
| $10.4M | 0.01% |
629,438
| – | – |
|
|
AFT
157
DELISTED
Apollo Senior Floating Rate Fund Inc.
AFT
| $10.3M | 0.01% |
617,746
| – | – |
|
|
FMI
158
DELISTED
Foundation Medicine, Inc.
FMI
| $10.3M | 0.01% |
255,790
+7,490
| +3% | +$301K |
|
159
Teladoc Health
TDOC
$1.35B
| $10.1M | 0.01% |
306,012
+21,012
| +7% | +$697K |
|
160
Weibo
WB
$2.83B
| $10.1M | 0.01% |
102,038
-11,059
| -10% | -$1.09M |
|
161
Codexis
CDXS
$218M
| $9.83M | 0.01% |
1,478,097
+16,684
| +1% | +$111K |
|
162
Digimarc
DMRC
$175M
| $9.57M | 0.01% |
261,462
+8,564
| +3% | +$313K |
|
163
Stratasys
SSYS
$866M
| $9.33M | 0.01% |
403,505
+25,705
| +7% | +$594K |
|
|
FARO
164
DELISTED
Faro Technologies
FARO
| $8.74M | 0.01% |
228,404
+10,424
| +5% | +$399K |
|
165
STAAR Surgical
STAA
$1.38B
| $8.7M | 0.01% |
698,742
+32,130
| +5% | +$400K |
|
166
Ambarella
AMBA
$3.44B
| $8.67M | 0.01% |
176,999
+56,899
| +47% | +$2.79M |
|
167
Schlumberger
SLB
$53.7B
| $8.31M | 0.01% |
119,127
| – | – |
|
|
ONC
168
BeOne Medicines Ltd. American Depositary Shares
ONC
$35.1B
| $8.28M | 0.01% |
80,010
+5,586
| +8% | +$578K |
|
169
CEVA Inc
CEVA
$534M
| $8.27M | 0.01% |
193,198
+9,798
| +5% | +$419K |
|
|
NCNA
170
NuCana
NCNA
$5.46M
| $8.27M | 0.01% |
+90
| New | +$8.27M |
|
|
BNFT
171
DELISTED
Benefitfocus, Inc.
BNFT
| $8.04M | 0.01% |
+238,850
| New | +$8.04M |
|
172
Microchip Technology
MCHP
$34.8B
| $7.42M | 0.01% |
165,320
| – | – |
|
|
HIMX
173
Himax Technologies
HIMX
$1.45B
| $7.39M | 0.01% |
675,800
| – | – |
|
|
MB
174
DELISTED
MINDBODY, Inc. Class A Common Stock
MB
| $6.88M | 0.01% |
266,264
+15,603
| +6% | +$403K |
|
|
LTRPA
175
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
| $6.71M | 0.01% |
543,314
| – | – |
|